Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Cerevel Therapeutics Holdings, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- 0 vs. Q4 2021
- Shares held
- 122.1M
- +3.49M (+2.9%) vs. Q4 2021
- Total value
- $4.27B
- +$428.6M (+11.1%) vs. Q4 2021
- New holders
- 23
- 32 more added
- Sold out
- 23
- 35 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CERE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $1.16K |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 2 | $20.7K |
| Q2 2024 | 231 | $6.42B |
| Q1 2024 | 210 | $6.67B |
| Q4 2023 | 195 | $6.61B |
| Q3 2023 | 119 | $3.07B |
| Q2 2023 | 125 | $4.41B |
| Q1 2023 | 119 | $3.30B |
| Q4 2022 | 125 | $4.23B |
| Q3 2022 | 115 | $3.76B |
| Q2 2022 | 109 | $3.28B |
| Q1 2022 | 107 | $4.27B |
| Q4 2021 | 107 | $3.84B |
| Q3 2021 | 94 | $3.51B |
| Q2 2021 | 82 | $2.65B |
| Q1 2021 | 62 | $1.37B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Cerevel Therapeutics Holdings, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 3,113,333 | $109.0M | 0.25% | 00.0% | Unchanged |
| BlackRock Inc. | 3,391,415 | $118.7M | 0.00% | −93,242−2.7% | Reduced |
| Vanguard Group Inc | 4,809,693 | $168.4M | 0.00% | +7,856+0.2% | Added |
| Perceptive Advisors LLC | 5,086,727 | $178.1M | 3.70% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 6,478,010 | $226.8M | 0.02% | +477,088+8.0% | Added |
| FMR LLC | 22,204,001 | $777.4M | 0.06% | +2,694,188+13.8% | Added |
| Bain Capital Investors LLC | 60,632,356 | $2.12B | 30.71% | 00.0% | Unchanged |
| RTW Investments, LP | 0 | $0 | 0.00% | −666,666−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −48,289−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −39,907−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −38,051−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −29,088−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −19,608−100.0% | Sold out |
| Putnam Investments LLC | 0 | $0 | 0.00% | −16,239−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −10,727−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −10,328−100.0% | Sold out |
| Boulder Hill Capital Management LP | 0 | $0 | 0.00% | −8,900−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −8,700−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −8,546−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −8,486−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −7,913−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −4,702−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −3,608−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −2,782−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −841−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −130−100.0% | Sold out |
| Tarbox Family Office, Inc. | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |